ArticleProceedings of the National Academy of Sciences of the United States of America2025

Targeting the complement lectin pathway with a highly specific MASP-2 inhibitor protects against renal ischemia-reperfusion injury.

Anjan K Bongoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.